Anti-Trypanosoma cruzi cross-reactive antibodies detected at high rate in non-exposed individuals living in non-endemic regions: seroprevalence and association to other viral serologies.
Cross-reactive antibodies are characterized by their recognition of antigens that are different from the trigger immunogen. This happens when the similarity between two different antigenic determinants becomes adequate enough to enable a specific binding with such cross-reactive antibodies. In the p...
Guardado en:
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9aa4f913716b413aba473498a8b8732a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:9aa4f913716b413aba473498a8b8732a |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:9aa4f913716b413aba473498a8b8732a2021-11-18T08:54:55ZAnti-Trypanosoma cruzi cross-reactive antibodies detected at high rate in non-exposed individuals living in non-endemic regions: seroprevalence and association to other viral serologies.1932-620310.1371/journal.pone.0074493https://doaj.org/article/9aa4f913716b413aba473498a8b8732a2013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24069315/?tool=EBIhttps://doaj.org/toc/1932-6203Cross-reactive antibodies are characterized by their recognition of antigens that are different from the trigger immunogen. This happens when the similarity between two different antigenic determinants becomes adequate enough to enable a specific binding with such cross-reactive antibodies. In the present manuscript, we report the presence, at an "abnormal" high frequency, of antibodies in blood samples from French human subjects cross-reacting with a synthetic-peptide antigen derived from a Trypanosoma cruzi (T. cruzi) protein sequence. As the vector of T. cruzi is virtually confined to South America, the parasite is unlikely to be the trigger immunogen of the cross-reactive antibodies detected in France. At present, the cross-reactive antibodies are measured by using an in-house ELISA method that employs the T. cruzi -peptide antigen. However, to underline their cross-reactive characteristics, we called these antibodies "Trypanosoma cruzi Cross Reactive Antibodies" or TcCRA. To validate their cross-reactive nature, these antibodies were affinity-purified from plasma of healthy blood donor and were then shown to specifically react with the T. cruzi parasite by immunofluorescence. Seroprevalence of TcCRA was estimated at 45% in serum samples of French blood donors while the same peptide-antigen reacts with about 96% of T. cruzi -infected Brazilian individuals. In addition, we compared the serology of TcCRA to other serologies such as HSV 1/2, EBV, HHV-6, CMV, VZV, adenovirus, parvovirus B19, mumps virus, rubella virus, respiratory syncytial virus, measles and enterovirus. No association was identified to any of the tested viruses. Furthermore, we tested sera from different age groups for TcCRA and found a progressive acquisition starting from early childhood. Our findings show a large seroprevalence of cross-reactive antibodies to a well-defined T. cruzi antigen and suggest they are induced by a widely spread immunogen, acquired from childhood. The etiology of TcCRA and their clinical relevance still need to be investigated.Esber S SabaLucie GueyffierMarie-Laure Dichtel-DanjoyBruno PozzettoThomas BourletFrançois GueyffierYahia MekkiHans PottelEster C SabinoPhilippe VanhemsMaan A ZreinPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 9, p e74493 (2013) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Esber S Saba Lucie Gueyffier Marie-Laure Dichtel-Danjoy Bruno Pozzetto Thomas Bourlet François Gueyffier Yahia Mekki Hans Pottel Ester C Sabino Philippe Vanhems Maan A Zrein Anti-Trypanosoma cruzi cross-reactive antibodies detected at high rate in non-exposed individuals living in non-endemic regions: seroprevalence and association to other viral serologies. |
description |
Cross-reactive antibodies are characterized by their recognition of antigens that are different from the trigger immunogen. This happens when the similarity between two different antigenic determinants becomes adequate enough to enable a specific binding with such cross-reactive antibodies. In the present manuscript, we report the presence, at an "abnormal" high frequency, of antibodies in blood samples from French human subjects cross-reacting with a synthetic-peptide antigen derived from a Trypanosoma cruzi (T. cruzi) protein sequence. As the vector of T. cruzi is virtually confined to South America, the parasite is unlikely to be the trigger immunogen of the cross-reactive antibodies detected in France. At present, the cross-reactive antibodies are measured by using an in-house ELISA method that employs the T. cruzi -peptide antigen. However, to underline their cross-reactive characteristics, we called these antibodies "Trypanosoma cruzi Cross Reactive Antibodies" or TcCRA. To validate their cross-reactive nature, these antibodies were affinity-purified from plasma of healthy blood donor and were then shown to specifically react with the T. cruzi parasite by immunofluorescence. Seroprevalence of TcCRA was estimated at 45% in serum samples of French blood donors while the same peptide-antigen reacts with about 96% of T. cruzi -infected Brazilian individuals. In addition, we compared the serology of TcCRA to other serologies such as HSV 1/2, EBV, HHV-6, CMV, VZV, adenovirus, parvovirus B19, mumps virus, rubella virus, respiratory syncytial virus, measles and enterovirus. No association was identified to any of the tested viruses. Furthermore, we tested sera from different age groups for TcCRA and found a progressive acquisition starting from early childhood. Our findings show a large seroprevalence of cross-reactive antibodies to a well-defined T. cruzi antigen and suggest they are induced by a widely spread immunogen, acquired from childhood. The etiology of TcCRA and their clinical relevance still need to be investigated. |
format |
article |
author |
Esber S Saba Lucie Gueyffier Marie-Laure Dichtel-Danjoy Bruno Pozzetto Thomas Bourlet François Gueyffier Yahia Mekki Hans Pottel Ester C Sabino Philippe Vanhems Maan A Zrein |
author_facet |
Esber S Saba Lucie Gueyffier Marie-Laure Dichtel-Danjoy Bruno Pozzetto Thomas Bourlet François Gueyffier Yahia Mekki Hans Pottel Ester C Sabino Philippe Vanhems Maan A Zrein |
author_sort |
Esber S Saba |
title |
Anti-Trypanosoma cruzi cross-reactive antibodies detected at high rate in non-exposed individuals living in non-endemic regions: seroprevalence and association to other viral serologies. |
title_short |
Anti-Trypanosoma cruzi cross-reactive antibodies detected at high rate in non-exposed individuals living in non-endemic regions: seroprevalence and association to other viral serologies. |
title_full |
Anti-Trypanosoma cruzi cross-reactive antibodies detected at high rate in non-exposed individuals living in non-endemic regions: seroprevalence and association to other viral serologies. |
title_fullStr |
Anti-Trypanosoma cruzi cross-reactive antibodies detected at high rate in non-exposed individuals living in non-endemic regions: seroprevalence and association to other viral serologies. |
title_full_unstemmed |
Anti-Trypanosoma cruzi cross-reactive antibodies detected at high rate in non-exposed individuals living in non-endemic regions: seroprevalence and association to other viral serologies. |
title_sort |
anti-trypanosoma cruzi cross-reactive antibodies detected at high rate in non-exposed individuals living in non-endemic regions: seroprevalence and association to other viral serologies. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2013 |
url |
https://doaj.org/article/9aa4f913716b413aba473498a8b8732a |
work_keys_str_mv |
AT esberssaba antitrypanosomacruzicrossreactiveantibodiesdetectedathighrateinnonexposedindividualslivinginnonendemicregionsseroprevalenceandassociationtootherviralserologies AT luciegueyffier antitrypanosomacruzicrossreactiveantibodiesdetectedathighrateinnonexposedindividualslivinginnonendemicregionsseroprevalenceandassociationtootherviralserologies AT marielauredichteldanjoy antitrypanosomacruzicrossreactiveantibodiesdetectedathighrateinnonexposedindividualslivinginnonendemicregionsseroprevalenceandassociationtootherviralserologies AT brunopozzetto antitrypanosomacruzicrossreactiveantibodiesdetectedathighrateinnonexposedindividualslivinginnonendemicregionsseroprevalenceandassociationtootherviralserologies AT thomasbourlet antitrypanosomacruzicrossreactiveantibodiesdetectedathighrateinnonexposedindividualslivinginnonendemicregionsseroprevalenceandassociationtootherviralserologies AT francoisgueyffier antitrypanosomacruzicrossreactiveantibodiesdetectedathighrateinnonexposedindividualslivinginnonendemicregionsseroprevalenceandassociationtootherviralserologies AT yahiamekki antitrypanosomacruzicrossreactiveantibodiesdetectedathighrateinnonexposedindividualslivinginnonendemicregionsseroprevalenceandassociationtootherviralserologies AT hanspottel antitrypanosomacruzicrossreactiveantibodiesdetectedathighrateinnonexposedindividualslivinginnonendemicregionsseroprevalenceandassociationtootherviralserologies AT estercsabino antitrypanosomacruzicrossreactiveantibodiesdetectedathighrateinnonexposedindividualslivinginnonendemicregionsseroprevalenceandassociationtootherviralserologies AT philippevanhems antitrypanosomacruzicrossreactiveantibodiesdetectedathighrateinnonexposedindividualslivinginnonendemicregionsseroprevalenceandassociationtootherviralserologies AT maanazrein antitrypanosomacruzicrossreactiveantibodiesdetectedathighrateinnonexposedindividualslivinginnonendemicregionsseroprevalenceandassociationtootherviralserologies |
_version_ |
1718421156575313920 |